CREDIT SUISSE AG/ - ARENA PHARMACEUTICALS INC ownership

ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 2 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of ARENA PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2021$23,286,000
-53.4%
250,553
-70.1%
0.01%
-55.6%
Q3 2021$49,954,000
-11.6%
838,833
+1.3%
0.03%
-10.0%
Q2 2021$56,496,000
-1.5%
828,384
+0.2%
0.03%
+3.4%
Q1 2021$57,345,000
-12.6%
826,400
-3.2%
0.03%
-9.4%
Q4 2020$65,619,000
+56.0%
854,072
+51.9%
0.03%
+23.1%
Q3 2020$42,051,000
+17.4%
562,258
-1.2%
0.03%0.0%
Q2 2020$35,831,000
+88.1%
569,198
+25.5%
0.03%
+62.5%
Q1 2020$19,050,000
-12.4%
453,581
-5.2%
0.02%0.0%
Q4 2019$21,741,000
+11.1%
478,686
+11.9%
0.02%
-5.9%
Q3 2019$19,573,000
-18.2%
427,635
+4.8%
0.02%
-19.0%
Q2 2019$23,917,000
+19.8%
407,927
-8.4%
0.02%
+16.7%
Q1 2019$19,968,000
+16.2%
445,411
+1.0%
0.02%0.0%
Q4 2018$17,182,000
-14.0%
441,139
+1.7%
0.02%0.0%
Q3 2018$19,969,000
+35.5%
433,946
+28.4%
0.02%
+28.6%
Q2 2018$14,733,000
-35.9%
337,882
-42.0%
0.01%
-33.3%
Q1 2018$22,994,000
+92.4%
582,138
+65.5%
0.02%
+90.9%
Q4 2017$11,951,000
+552.7%
351,820
+390.0%
0.01%
+450.0%
Q3 2017$1,831,000
+91.1%
71,800
+26.4%
0.00%
+100.0%
Q2 2017$958,00056,7880.00%
Other shareholders
ARENA PHARMACEUTICALS INC shareholders Q1 2022
NameSharesValueWeighting ↓
Prosight Management, LP 252,500$11,320,0004.95%
Rubric Capital Management LP 857,103$38,424,0003.59%
PFM Health Sciences, LP 3,255,230$145,932,0003.22%
Partner Investment Management, L.P. 40,605$1,820,0002.10%
DAFNA Capital Management LLC 93,942$4,211,0001.82%
Atika Capital Management LLC 195,000$8,742,0001.78%
Perceptive Advisors 1,400,171$62,770,0001.77%
EMORY UNIVERSITY 47,779$2,142,0001.51%
Rhenman & Partners Asset Management AB 234,558$10,515,0001.23%
Eversept Partners, LP 75,721$3,394,5720.99%
View complete list of ARENA PHARMACEUTICALS INC shareholders